Share this post on:

Product Name :
Burixafor Hydrobromide

Search keywords :
Burixafor (hydrobromide)

drugId :
null

Target Vo:
C-X-C motif chemokine receptor 4

Target Vo Short Name :
CXCR4

Moa_Name:
C-X-C motif chemokine receptor 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
TaiGen Biotechnology Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 2 Clinical

China Termination Status :
Phase 1 Clinical

Highest Status:
Discontinued

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DLAT Antibody (YA912)
ATG4A Antibody
CXCR2 Antibody: CXCR2 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR2 polyclonal antibody. CXCR2 Antibody can be used for: WB, ELISA expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.

Share this post on:

Author: Betaine hydrochloride